New! The CIHR - Institute of Cancer Research & CAPO Research Excellence Award in Psychosocial Oncology
2025 Call for Nominations
The purpose of this award is to recognize an individual who, in the opinion of the Awards Committee and the Board of Directors Association, has made a significant research contribution to Psychosocial Oncology. This award will follow a nomination and selection process as outlined in the Award Terms of Reference.
Eligibility
- The nominee must be within seven years of completing their postgraduate, fellowship, or equivalent specialist training (defined as a PhD or MD or equivalent).
Application Criteria
- The purpose of this award is to recognize an individual who, in the opinion of the Awards Committee and the Board of Directors of the Association, has made a significant research contribution to psychosocial oncology.
- The award will be presented at the annual CAPO conference by the Chair of the Awards Committee or an Institute designate.
- The winner(s) agree to have their name(s) released as winners of the award and to be featured on CHIR-ICR's various communication channels (e.g., website, social media, newsletter).
Anticipated Timeline
- Late 2024: Launch of call for applications
- Spring 2025: Notice of decisions
- Awarded at CAPO conference
Application Process
- Details to be published fall 2024
Award
- Recognition award and reimbursement for travel expenses to the CAPO annual conference up to $1000
2024 Award Receipient for Research excellence: Dr. Sylvie Lambert
| Past Winners
|
Sylvie Lambert, RN, PhD is Associate Professor and Associate Director of Research at the Ingram School of Nursing, McGill University; and Scientist at the St. Mary’s Research Centre, Montreal. Sylvie is also the recipient of a CIHR Canada Research Chair (Tier 2) in self-care and illness self-management support interventions. In this position, the objectives of her research programs include: 1) developing and evaluating low-cost self-care and illness self-management interventions that are sustainable to enhance translation in practice, 2) implementing real-world patient-reported outcome (PRO) and caregiver-reported outcome (CRO) screening programs, 3) adapting evidence-based self-management interventions to the needs of patients from a culturally and linguistically diverse background and their caregivers, and 4) using advanced psychometric approaches for improving the precision and efficiency of outcome evaluations. One of Dr Lambert’s key study is TEMPO, which stands for a tailored web-based self-management and physical activity program for men with prostate cancer and their caregivers. A pan-canadian trial of TEMPO was recently funded by CIHR. She is also leading e-IMPAQc for the electronic implementation of patient-reported outcomes across the cancer continuum in Quebec. Sylvie has received national and international recognition of her work in the form of several awards and prizes.
New! The CIHR - Institute of Cancer Research & CAPO Early Career Investigator in Psychosocial Oncology Award
2025 Call for Nominations
The CIHR - Institute of Cancer Research & CAPO Early Career Investigator Award in Psychosocial Oncology honours a new investigator for outstanding contributions to research in the field of psychosocial oncology. Candidates must be within seven years of completing their postgraduate, fellowship or equivalent specialist training (defined as a PhD or MD or equivalent).
This award will follow a nomination and selection process as outlined in the Award Terms of Reference.
Eligibility
- The nominee must be within seven years of completing their postgraduate, fellowship, or equivalent specialist training (defined as a PhD or MD or equivalent).
Application Criteria
- The purpose of this award is to recognize a new investigator for outstanding contributions to research in the field of psychosocial oncology.
- The award will be presented at the annual CAPO conference by the Chair of the Awards Committee or an Institute designate.
- The winner(s) agree to have their name(s) released as winners of the award and to be featured on CHIR-ICR's various communication channels (e.g., website, social media, newsletter).
Anticipated Timeline
- Late 2024: Launch of call for applications
- Spring 2025: Notice of decisions
- Awarded at CAPO conference
Application Process
- Details to be published fall 2024
Award
- Recognition award and reimbursement for travel expenses to the CAPO annual conference up to $1000
2024 Early Career Investigator Award Recipient: Dr. Gilla Shapiro
Over the past decade, Dr. Shapiro’s research has focused on cancer prevention, health decision making, and supporting diverse patients with cancer. Dr. Shapiro’s research incorporates a health equity lens, and she investigates factors that contribute to making important health decisions (such as HPV vaccination), developing evidence-based interventions in diverse patients with cancer, improving health services, and enhancing patients’ experience. Her scholarly work has resulted in over 60 publications as well as several book chapters, commissioned reports, op-ed pieces, and patient education booklets. Dr. Shapiro’s work has been recognized through awards including CIHR’s Institute of Health Sciences and Policy Research Rising Star Award, the Royal Society of Canada’s Alice Wilson Award, and the CPA’s Health Psychology and Behavioural Medicine Section's Early Career Award. Her research has been funded by the Canadian Institutes of Health Research, Canadian Immunization Research Network, and the Canadian Cancer Society. | Past Winners
|
Dr. Gilla Shapiro is a Psychologist and Clinician Scientist at the Department of Supportive Care, Princess Margaret Cancer Centre, and an Assistant Professor (Status-Only) at the Department of Psychiatry, Institute of Medical Science, and the Dalla Lana School of Public Health, University of Toronto. The Canadian Association of 189 Queen Street East, Suite 1 
 | Sitemap |
|
